Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

Clinical trial NCT03059641 · COMPLETED

Trial details

NCT number: NCT03059641
Sponsor: Geneplus-Beijing Co. Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Neoplasms Lung Cancer, Nonsmall Cell Adenocarcinoma of Lung Squamous Cell Lung Cancer

Start date: 2017-02-22
Primary completion: 2019-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.